Assertio Therapeutics Stock Technical Analysis
| ASRT Stock | USD 11.68 0.34 2.83% |
As of the 10th of February, Assertio Therapeutics shows the Standard Deviation of 3.6, mean deviation of 2.57, and Risk Adjusted Performance of (0.02). Assertio Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Assertio Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Assertio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AssertioAssertio Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is there potential for Pharmaceuticals market expansion? Will Assertio introduce new products? Factors like these will boost the valuation of Assertio Therapeutics. If investors know Assertio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Assertio Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Assertio Therapeutics requires distinguishing between market price and book value, where the latter reflects Assertio's accounting equity. The concept of intrinsic value - what Assertio Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Assertio Therapeutics' price substantially above or below its fundamental value.
Understanding that Assertio Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assertio Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Assertio Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Assertio Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Assertio Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Assertio Therapeutics.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Assertio Therapeutics on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Assertio Therapeutics or generate 0.0% return on investment in Assertio Therapeutics over 90 days. Assertio Therapeutics is related to or competes with INC Research, Nutriband, XBiotech, Fortress Biotech, Acrivon Therapeutics, Tscan Therapeutics, and Pulmonx Corp. Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and... More
Assertio Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Assertio Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Assertio Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 16.6 | |||
| Value At Risk | (4.63) | |||
| Potential Upside | 6.07 |
Assertio Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Assertio Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Assertio Therapeutics' standard deviation. In reality, there are many statistical measures that can use Assertio Therapeutics historical prices to predict the future Assertio Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.12) |
Assertio Therapeutics February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.57 | |||
| Coefficient Of Variation | (2,898) | |||
| Standard Deviation | 3.6 | |||
| Variance | 12.96 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 16.6 | |||
| Value At Risk | (4.63) | |||
| Potential Upside | 6.07 | |||
| Skewness | 0.7488 | |||
| Kurtosis | 2.02 |
Assertio Therapeutics Backtested Returns
Assertio Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0345, which signifies that the company had a -0.0345 % return per unit of risk over the last 3 months. Assertio Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Assertio Therapeutics' Standard Deviation of 3.6, mean deviation of 2.57, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.15, which signifies a somewhat significant risk relative to the market. Assertio Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Assertio Therapeutics is expected to follow. At this point, Assertio Therapeutics has a negative expected return of -0.12%. Please make sure to confirm Assertio Therapeutics' jensen alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if Assertio Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.14 |
Insignificant reverse predictability
Assertio Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Assertio Therapeutics time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Assertio Therapeutics price movement. The serial correlation of -0.14 indicates that less than 14.0% of current Assertio Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.14 | |
| Spearman Rank Test | -0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 1.44 |
Assertio Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Assertio Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Assertio Therapeutics across different markets.
About Assertio Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Assertio Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Assertio Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Assertio Therapeutics price pattern first instead of the macroeconomic environment surrounding Assertio Therapeutics. By analyzing Assertio Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Assertio Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Assertio Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Assertio Therapeutics February 10, 2026 Technical Indicators
Most technical analysis of Assertio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Assertio from various momentum indicators to cycle indicators. When you analyze Assertio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.57 | |||
| Coefficient Of Variation | (2,898) | |||
| Standard Deviation | 3.6 | |||
| Variance | 12.96 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 16.6 | |||
| Value At Risk | (4.63) | |||
| Potential Upside | 6.07 | |||
| Skewness | 0.7488 | |||
| Kurtosis | 2.02 |
Assertio Therapeutics February 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Assertio stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 5,940 | ||
| Daily Balance Of Power | (0.39) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 11.87 | ||
| Day Typical Price | 11.81 | ||
| Price Action Indicator | (0.36) |
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.